| Emitents | Grindeks, AS (5299006DWR32NKWM1O86) |
| Veids | Būtiski notikumi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2011-12-19 12:51:28 |
| Versijas komentārs | |
| Teksts |
According to the information published by the news agency LETA, JSC „Grindeks” approves the negotiations with Mr. Juris Bundulis, the Deputy State Secretary of the Health Ministry of Latvia, as a candidate of new Chairman of the Board of JSC „Grindeks”. In accordance with the election procedure, the Chairman
of the Board is elected by Supervisory Council. It is planned that
the Meeting of the Supervisory Council will be held
shortly.
Now, until further decisions the Board of JSC „Grindeks”
will continue to work in composition of two Board Members - Vadims
Rabsha, Finance and Administrative director and Lipmans Zeligmans,
Director of the Final Dosage Forms Manufacturing.
About „Grindeks”
„Grindeks” is the leading pharmaceutical
company in the Baltic States. Its main fields of action are:
research, development, manufacturing and sale of original products,
generics and active pharmaceutical ingredients. The Group of
„Grindeks” consists of four subsidiary companies
in Latvia, Estonia and Russia, as well representative offices in
ten countries.
„Grindeks” specializes in the heart and
cardiovascular, CNS and anti-cancer medication therapeutic groups.
A range of products covers a successful combination of original
products and generics, with the original products Mildronate® and
Ftorafur® and more than 100 forms of effective and safe generics
included therein. Currently „Grindeks”
produces 16 active pharmaceutical ingredients.
Products of the company are exported to 50 countries and
its export comprises more than 95% of the total turnover. The main
markets are: Russia and other CIS countries, the Baltic States,
Germany and the Netherlands. In 2010 The Ministry of Economics of
Republic of Latvia and Investment and Development Agency of Latvia
awarded „Grindeks” as the most export
potential company of Latvia.
During the last years the company realized many
considerable investment projects in purpose to increase production
capacity and develop infrastructure and invested 32.7 million lats
within five years.
JSC „Grindeks” shares are listed in the Official List of "NASDAQ OMX Riga". Major shareholders of JSC „Grindeks” are Kirovs Lipmans - 33.29%, Anna Lipmane - 16.69%, "Skandinaviska Enskilda Banken" - 12.42%, "AB.LV Private Equity fund 2010" - 11.38%, "Swedbank" AS Clients Account - 6.87%. Further information: Laila Kļaviņa
Head of the Communications Department, JSC „Grindeks” Phones: (+371) 67083370, (+371) 29256012 Fax: (+371) 67083505 laila.klavina@grindeks.lv
|
| Pielikumi |
|